Federal (United States) · Session law
Division CC
53 sections
1 group
24 sections filed directly here
- Pub. L. 116-260, div. CC, tit. II, sec. 201ELIMINATING DSH REDUCTIONS FOR FISCAL YEARS 2021 THROUGH 2023.Enacted
- Pub. L. 116-260, div. CC, tit. II, sec. 202SUPPLEMENTAL PAYMENT REPORTING REQUIREMENTS.Enacted
- Pub. L. 116-260, div. CC, tit. II, sec. 203MEDICAID SHORTFALL AND THIRD PARTY PAYMENTS.Enacted
- Pub. L. 116-260, div. CC, tit. II, sec. 204EXTENSION OF MONEY FOLLOWS THE PERSON REBALANCING DEMONSTRATION.Enacted
- Pub. L. 116-260, div. CC, tit. II, sec. 205EXTENSION OF SPOUSAL IMPOVERISHMENT PROTECTIONS.Enacted
- Pub. L. 116-260, div. CC, tit. II, sec. 206EXTENSION OF COMMUNITY MENTAL HEALTH SERVICES DEMONSTRATION PROGRAM.Enacted
- Pub. L. 116-260, div. CC, tit. II, sec. 207CLARIFYING AUTHORITY OF STATE MEDICAID FRAUD AND ABUSE CONTROL UNITS TO INVESTIGATE AND PROS- ECUTE CASES OF MEDICAID PATIENT ABUSE AND NEGLECT IN ANY SETTING.Enacted
- Pub. L. 116-260, div. CC, tit. II, sec. 208MEDICAID COVERAGE FOR CITIZENS OF FREELY ASSOCIATED STATES.Enacted
- Pub. L. 116-260, div. CC, tit. II, sec. 209MEDICAID COVERAGE OF CERTAIN MEDICAL TRANSPORTATION.Enacted
- Pub. L. 116-260, div. CC, tit. II, sec. 210PROMOTING ACCESS TO LIFE-SAVING THERAPIES FOR MEDICAID ENROLLEES BY ENSURING COVERAGE OF ROU- TINE PATIENT COSTS FOR ITEMS AND SERVICES FUR- NISHED IN CONNECTION WITH PARTICIPATION IN QUALI- FYING CLINICAL TRIALS.Enacted
- Pub. L. 116-260, div. CC, tit. III, sec. 301EXTENSION OF TANF, CHILD CARE ENTITLEMENT TO STATES, AND RELATED PROGRAMS.Enacted
- Pub. L. 116-260, div. CC, tit. III, sec. 302PERSONAL RESPONSIBILITY EDUCATION EXTENSION.Enacted
- Pub. L. 116-260, div. CC, tit. III, sec. 303SEXUAL RISK AVOIDANCE EDUCATION EXTENSION.Enacted
- Pub. L. 116-260, div. CC, tit. III, sec. 304EXTENSION OF SUPPORT FOR CURRENT HEALTH PROFESSIONS OPPORTUNITY GRANTS.Enacted
- Pub. L. 116-260, div. CC, tit. III, sec. 305EXTENSION OF MARYLEE ALLEN PROMOTING SAFE AND STABLE FAMILIES PROGRAM AND STATE COURT SUP- PORT.Enacted
- Pub. L. 116-260, div. CC, tit. IV, sec. 401REQUIRING CERTAIN MANUFACTURERS TO REPORT DRUG PRICING INFORMATION WITH RESPECT TO DRUGS UNDER THE MEDICARE PROGRAM.Enacted
- Pub. L. 116-260, div. CC, tit. IV, sec. 402EXTENDED MONTHS OF COVERAGE OF IMMUNOSUPPRESSIVE DRUGS FOR KIDNEY TRANSPLANT PATIENTS AND OTHER RENAL DIALYSIS PROVISIONS.Enacted
- Pub. L. 116-260, div. CC, tit. IV, sec. 403PERMITTING DIRECT PAYMENT TO PHYSICIAN ASSISTANTS UNDER MEDICARE.Enacted
- Pub. L. 116-260, div. CC, tit. IV, sec. 404ADJUSTING CALCULATION OF HOSPICE CAP AMOUNT UNDER MEDICARE.Enacted
- Pub. L. 116-260, div. CC, tit. IV, sec. 405SPECIAL RULE FOR DETERMINATION OF ASP IN CASES OF CERTAIN NONCOVERED SELF-ADMINISTERED DRUG PRODUCTS.Enacted
- Pub. L. 116-260, div. CC, tit. IV, sec. 406MEDICAID IMPROVEMENT FUND.Enacted
- Pub. L. 116-260, div. CC, tit. IV, sec. 407ESTABLISHING HOSPICE PROGRAM SURVEY AND ENFORCEMENT PROCEDURES UNDER THE MEDICARE PROGRAM.Enacted
- Pub. L. 116-260, div. CC, tit. IV, sec. 408MEDICARE IMPROVEMENT FUND.Enacted
- Pub. L. 116-260, div. CC, tit. V, sec. 501IMPLEMENTATION FUNDING.Enacted